Management of Acute Exacerbations in Chronic Pain

Initial Assessment and Treatment Approach

When a patient with controlled chronic pain reports new or worsening pain, immediately investigate for new pathology rather than simply increasing existing analgesics, as this new symptom requires thorough reevaluation and may necessitate added treatments or dose adjustments only after determining the underlying cause, according to the Clinical Infectious Diseases guidelines 1
The American College of Physicians recommends systematically determining whether the exacerbation represents new pathology requiring investigation, end-of-dose failure, treatment-resistant pain, or psychosocial disruption, with comprehensive documentation and consultation with pain specialists when available 1
Use the ultra-brief PEG tool for rapid assessment in busy clinical settings, which evaluates pain intensity, enjoyment of life, and general activity, as suggested by Clinical Infectious Diseases and Praxis Medical Insights 1, 2

Cognitive Behavioral Therapy (CBT) should be initiated or intensified for pain exacerbations to promote adaptive behaviors and address maladaptive ones, with a focus on developing coping strategies for anxiety related to new or worsening pain, as recommended by Clinical Infectious Diseases 3, 4
Physical and occupational therapy are strongly recommended and should be adjusted to address the specific exacerbation pattern, with a focus on improving functional goals and quality of life, according to Clinical Infectious Diseases and Praxis Medical Insights 3, 4, 2
Yoga is strongly recommended specifically for chronic neck/back pain, headache, rheumatoid arthritis, and general musculoskeletal pain exacerbations, as suggested by Clinical Infectious Diseases and Praxis Medical Insights 3, 4, 2
Hypnosis is strongly recommended when the exacerbation involves neuropathic pain components, as recommended by Clinical Infectious Diseases and Praxis Medical Insights 3, 4, 2

For neuropathic pain exacerbations, gabapentin is the first-line oral pharmacological treatment, titrating to 2400 mg per day in divided doses, with improvements in sleep scores, as recommended by Clinical Infectious Diseases 3
For musculoskeletal pain exacerbations, acetaminophen up to 3 grams daily is the safest first-line option, particularly in patients with liver disease, heart problems, or kidney disease, as suggested by Praxis Medical Insights 2, 6
NSAIDs may be used cautiously but must be avoided in patients with cirrhosis or kidney stones, as recommended by Praxis Medical Insights 2, 6
For breakthrough pain in opioid-treated patients, small amounts of short-acting opioid analgesics should be prescribed, with agreement on the number of pills dispensed, frequency of use, and expected treatment duration, as recommended by Clinical Infectious Diseases 7

For patients on methadone maintenance, split methadone into 6-8 hour doses to lengthen active analgesic effects and achieve continuous pain control during exacerbations, with addition of 5-10% of the current methadone dose as afternoon and evening doses, as recommended by Clinical Infectious Diseases and Praxis Medical Insights 7, 2
For patients on buprenorphine maintenance, increase buprenorphine dosage in divided doses as the initial step, with addition of a long-acting potent opioid if maximal buprenorphine doses are reached, as recommended by Clinical Infectious Diseases and Praxis Medical Insights 7, 2

Develop and activate interdisciplinary teams for complex pain exacerbations, especially with co-occurring substance use or psychiatric disorders, including primary care providers, physical and occupational therapists, psychologists, case managers, and pain specialists, as recommended by Clinical Infectious Diseases and Praxis Medical Insights 3, 1, 2
Engage in frequent communication with the patient and their support system at a health literacy level appropriate for them, with scheduled longer appointment times to establish and clarify goals of care, as recommended by Clinical Infectious Diseases 3

Do not assume existing chronic pain treatment is sufficient for new pain symptoms, as this is a dangerous misconception that delays diagnosis of new pathology, as warned by Clinical Infectious Diseases 1
Do not fear adding opioids to existing regimens due to respiratory depression concerns in patients whose pain was previously controlled, as this fear leads to undertreatment, as warned by Clinical Infectious Diseases 1
Do not interpret new pain reports as opioid addiction, but carefully distinguish between pseudo-addiction and true substance use disorder, as warned by Clinical Infectious Diseases 1
Avoid focusing solely on unproven interventions, as this delays implementation of evidence-based treatments, as warned by Praxis Medical Insights 2

Focus assessments on achieving functional goals, decreasing pain severity, improving quality of life, and identifying treatment-related adverse events or aberrant behaviors, as recommended by Clinical Infectious Diseases and Praxis Medical Insights 1, 2
Regular assessment of liver function, renal function, and cardiac status is essential when using pharmacological treatments, as recommended by Praxis Medical Insights 2, 6
For patients on methadone, perform initial electrocardiogram screening to identify QTc prolongation, with interval follow-up after dose changes, as recommended by Clinical Infectious Diseases 7